← Back
Data updated: Mar 10, 2026
IMMUNOGEN INC
Oncology
IMMUNOGEN INC is a biotechnology company focused on Oncology.
2022
Since
1
Drugs
-
Trials
2
Approved (2yr)
Key Drugs
No active drugs
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Oncology 100%
1 drugs Phase 3: 2 Phase 1: 3
Pipeline Strength Pro
Loading...
Active (1)
Discontinued (0)
Company Info
- First Approval
- 2022-11-14
- Latest
- 2025-07-14
- Applications
- 1